CSF3 and breast cancer: (2020), who in a systematic review and meta-analysis demonstrated that PEGylated G-CSF significantly reduces the incidence of febrile neutropenia and is at least as effective, if not superior, to filgrastim in breast cancer patients receiving chemotherapy (17).